retatrutide weight loss clinical trial results Phase 3: TRIUMPH Program 2026 Eli Lilly's triple agonist, retatrutide,

Others may move in the opposite direction

Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain

Patients should be advised to maintain adequate hydration and to seek medical advice if symptoms are prolonged or severe

Retatrutide Efficacy: The Phase 2 obesity trial, published in the New England Journal of Medicine (NEJM) , provided the most impressive initial results

Education on the importance of good sleep hygiene should be provided as part of lifestyle counselling to patients on GLP-1 based therapy

Available for an Extra Fee A health coach and a Discord community sit alongside the medication plans, but theyre not bundled into the medication price